TITLE

Intestinal absorption of the bile acid analogue (75)Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration

AUTHOR(S)
Lanzini A; De Tavonatti M G; Panarotto B; Scalia S; Mora A; Benini F; Baisini O; Lanzarotto F
PUB. DATE
September 2003
SOURCE
Gut;Sep2003, Vol. 52 Issue 9, p1371
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
BACKGROUND: Whether ileal absorption of bile acid is up or downregulated in chronic cholestasis is still debated, and most evidence has come from animal studies. AIMS: To compare ileal bile acid absorption in patients with primary biliary cirrhosis (PBC) and in healthy control subjects, and to assess the effect of ursodeoxycholic acid (UDCA). PATIENTS: We studied 14 PBC patients before and during (n=11) UDCA administration, 14 healthy control subjects, and 14 Crohn's disease patients (as disease controls). METHODS: We used cholescintigraphy to measure retention in the enterohepatic circulation over five successive days of the bile acid analogue (75)Se-homocholic acid-taurine ((75)SeHCAT) as an index of ileal bile acid absorption. Results were expressed as (75)SeHCAT fractional turnover rate (FTR) and t(1/2)12. RESULTS: (75)SeHCAT FTR was 0.19 (0.11)/day, 0.34 (0.11)/day (p<0.001), and 0.83 (0.32)/day in PBC patients, healthy controls (p<0.0001), and Crohn's patients (p<0.001), respectively, which increased to 0.36 (0.16)/day in PBC patients during UDCA treatment (p<0.005). (75)SeHCAT t(1/2)12 was 4.8 (2.1) days in PBC patients, 2.2 (0.5) days (p<0.001) in healthy controls, and 1.0 (0.5) days (p<0.001) in Crohn's disease patients. (75)SeHCAT t(1/2)12 decreased to 2.2 (0.93) days (p< 0.001) in PBC patients during UDCA treatment. CONCLUSIONS: Our results support the concept that ileal bile acid absorption is upregulated in PBC patients, and that this effect may contribute towards damaging the cholestatic liver. This upregulation of bile acid absorption is abolished by UDCA.
ACCESSION #
10631326

 

Related Articles

  • LXR Alpha Transactivates Mouse Organic Solute Transporter Alpha and Beta via IR-1 Elements Shared with FXR. Masae Okuwaki; Tappei Takada; Yuki Iwayanagi; Saori Koh; Yoshiaki Kariya; Hiroshi Fujii; Hiroshi Suzuki // Pharmaceutical Research;Feb2007, Vol. 24 Issue 2, p390 

    AbstractPurpose??Recently identified organic solute transporter (Ost) ? and ? are located on the basolateral membrane of enterocytes and may be responsible for the intestinal absorption of many substrates including bile acids. In the present study, the mechanism governing the transcriptional...

  • Conditional Gata4 deletion in mice induces bile acid absorption in the proximal small intestine. Beuling, Eva; Kerkhof, Ilona M.; Nicksa, Grace A.; Giuffrida, Michael J.; Haywood, Jamie; aan de Kerk, Daniel J.; Piaseckyj, Christina M.; Pu, William T.; Buchmiller, Terry L.; Dawson, Paul A.; Krasinski, Stephen D. // Gut;Jul2010, Vol. 59 Issue 7, p888 

    Background and aims The transcription factor GATA4 is expressed throughout most of the small intestine except distal ileum, and restricts expression of the apical sodium-dependent bile acid transporter (ASBT), the rate-limiting intestinal bile acid transporter, to distal ileum. The hypothesis...

  • Treatment Effect of Rifampicin on Cholestasis. Chen, Jiezhong; Raymond, Kenneth // Internet Journal of Pharmacology;2006, Vol. 4 Issue 2, p4 

    Rifampicin, a semisynthetic antibiotic, has been discovered serendipitously to have beneficial effect on cholestasis. The mechanism, as recently demonstrated, is its induction of pregnane X receptor to regulate the genes involved in bile acids biosynthesis, detoxification and transportation....

  • Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene. Wasmuth, H. E.; Glantz, A.; Keppeler, H.; Simon, E.; Bartz, C.; Rath, W.; Mattsson, L.-Å.; Marschall, H.-U.; Lammert, F. // Gut;Feb2007, Vol. 56 Issue 2, p265 

    Background: Intrahepatic cholestasis of pregnancy (ICP) is characterised by troublesome maternal pruritus, raised serum bile acid levels and increased fetal risk. Mutations of the ABCB4 gene encoding the hepatobiliary phospholipid transporter have been identified in a small proportion of...

  • Pruritus of Cholestasis Treated with Plasma Perfusion. Carey, William D.; Smith, James; Asanuma, Yoshihiro; Malchesky, Paul; Ferguson, D. Roy; Greenstreet, Richard; Nose, Yukihiko // American Journal of Gastroenterology;Oct1981, Vol. 76 Issue 4, p330 

    Patients with uncontrollable pruritus secondary to cholestatic liver disease were subjected to plasma perfusion in an attempt to remove the toxins responsible for this symptom. The improvement in the degree of pruritus was dramatic and surprisingly long-lasting in five of six patients. One...

  • Eupatilin attenuates bile acid-induced hepatocyte apoptosis. Park, Su Cheol; Yoon, Jung-Hwan; Kim, Won; Gwak, Geum-Youn; Kim, Kang Mo; Lee, Sung-Hee; Lee, Soo-Mi; Lee, Hyo-Suk // Journal of Gastroenterology;Aug2006, Vol. 41 Issue 8, p772 

    In cases of cholestasis, bile acids induce hepatocyte apoptosis by activating death receptor-mediated apoptotic signaling cascades. Eupatilin (5,7-dihydroxy-3,4,6-trimethoxyflavone) is a pharmacologically active ingredient found in Artemisia asiatica and exhibits cytoprotective effects against...

  • Increased susceptibility for intrahepatic cholestasis ofpregnancy and contraceptive-induced cholestasis in carriersof the 1331T>C polymorphism in the bile salt export pump. Meier, Yvonne; Zodan, Tina; Lang, Carmen; Zimmermann, Roland; Kullak-Ublick, Gerd A.; Meier, Peter J.; Stieger, Bruno; Pauli-Magnus, Christiane // World Journal of Gastroenterology;1/7/2008, Vol. 14 Issue 1, p38 

    AIM: To study the association of three common ABCB11 and ABCC2 polymorphisms (ABCB11: 1331T>C → V444A; ABCC2: 3563T>A → V1188E and 4544G>A → C1515Y) with intrahepatic cholestasis of pregnancy (ICP) and contraceptive-induced cholestasis (CIC). METHODS: ABCB11 and ABCC2...

  • Bile Acids Affect Liver Mitochondrial Bioenergetics: Possible Relevance for Cholestasis Therapy. Rolo, Anabela P.; Oliveira, Paulo J.; Moreno, António J. M.; Palmeira, Carlos M. // Toxicological Sciences;Sep2000, Vol. 57 Issue 1, p177 

    It has been pointed out that intracellular accumulation of bile acids cause hepatocyte injury in cholestatic disease process. This study was aimed to test if cytotoxicity of these compounds is mediated through mitochondria dysfunction. Bile acids effects on isolated rat liver mitochondrial were...

  • Erratum: Not All “Phates” Are Created Equal. McGowan, John; Cleveland, Mark vB; Di Palma, Jack A; Rodriguez, Reynaldo // American Journal of Gastroenterology;Sep2010, Vol. 105 Issue 9, p2123 

    Corrections to articles are presented including the wrong information in the editorial "A randomized clinical study evaluating the safety and efficacy of a new, reduced-volume, oral sulfate colon-cleansing preparation for colonoscopy" published in the 2009 issue, incorrect use of term in the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics